… first-in-human, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate JK07 in subjects with heart failure with reduced ejection fraction
用户wgPsi57cCaAs
2天前
22
10
待确认
帖子自动结束时间: 2025-06-07 10:26:39
1. 请及时下载文件确认是否正确, 系统将在 2025-06-10 11:33:04 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://www.sciencedirect.com/science/article/abs/pii/S1071916423008485
其他信息:
WH Tang, J Steiner, M Kassi, MT Wheeler…
… of Cardiac Failure, 2024
Elsevier
… A Phase 1 SAD study was conducted to assess safety, pharmacokinetics, and exploratory activity of JK07 in subjects with HFrEF. Eligible subjects were NYHA class II-III, aged 18 - 80 …
